4basebio PLC (LON:4BB – Get Free Report) insider Amy Walker bought 1,151 shares of the firm’s stock in a transaction dated Friday, February 28th. The shares were acquired at an average price of GBX 1,120 ($14.12) per share, for a total transaction of £12,891.20 ($16,250.09).
4basebio Trading Down 5.9 %
4BB stock traded down GBX 69 ($0.87) during trading on Monday, hitting GBX 1,091 ($13.75). The company had a trading volume of 3 shares, compared to its average volume of 827. The stock has a market cap of £139.76 million, a price-to-earnings ratio of -1,398.72 and a beta of 1.09. The company has a quick ratio of 3.52, a current ratio of 2.73 and a debt-to-equity ratio of 201.47. The firm has a 50-day moving average price of GBX 1,178.90 and a 200-day moving average price of GBX 1,280.77. 4basebio PLC has a 12 month low of GBX 821 ($10.35) and a 12 month high of GBX 1,820 ($22.94).
About 4basebio
Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.
Featured Stories
- Five stocks we like better than 4basebio
- 5 Top Rated Dividend Stocks to Consider
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- The 3 Best Fintech Stocks to Buy Now
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for 4basebio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4basebio and related companies with MarketBeat.com's FREE daily email newsletter.
